Related Experiment Video
Updated: Mar 26, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
25.5K
Botulinum Toxin to Treat Neurogenic Bladder
Christopher P Smith1, Michael B Chancellor2
1Scott Department of Urology, Baylor College of Medicine, Houston, Texas.
Seminars in Neurology
|February 12, 2016
Summary
Neurogenic bladder (NGB) causes incontinence and impacts quality of life. OnabotulinumtoxinA (onaBoNT-A) offers an effective second-line treatment option for NGB patients, improving outcomes and reducing care burdens.
Area of Science:
- Urology
- Neurology
- Pharmacology
Background:
- Neurogenic bladder (NGB) results from impaired neural control, leading to urinary incontinence.
- NGB significantly impacts patient quality of life and creates a substantial care burden.
- Anticholinergic medications often fail, necessitating alternative treatments like botulinum toxin.
Purpose of the Study:
- To review key clinical trial data supporting the FDA approval of onabotulinumtoxinA (onaBoNT-A) for NGB.
- To summarize recent long-term efficacy and safety data for onaBoNT-A in NGB patients.
Main Methods:
- Review of pivotal clinical trials and post-marketing studies.
- Analysis of efficacy and safety data from randomized controlled trials and observational studies.
Main Results:
- OnabotulinumtoxinA (onaBoNT-A) demonstrated significant efficacy in reducing urinary incontinence episodes in NGB patients.
- Long-term data indicate sustained effectiveness and an acceptable safety profile for onaBoNT-A treatment.
- Improvements in quality of life measures were observed in patients treated with onaBoNT-A.
Conclusions:
- OnabotulinumtoxinA (onaBoNT-A) is an effective second-line therapy for neurogenic detrusor overactivity in NGB.
- The data support the continued use of onaBoNT-A for managing NGB-related urinary incontinence.
- Long-term treatment with onaBoNT-A offers sustained benefits for patients with NGB.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.4K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.4K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.5K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.5K
01:26The Micturition Reflex
3.5K
Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating...
3.5K
01:23Urinary Bladder
4.2K
The urinary bladder is a hollow, muscular sac that temporarily stores urine before it is expelled from the body. It can hold approximately 600 mL of urine prior to micturition. The bladder is retroperitoneal and located behind the pubic symphysis in the pelvic floor.
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
4.2K
01:28Classification of Skeletal Muscle Relaxants
3.3K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.3K